SYnAbs produces innovative monoclonal antibodies against poor immunogenic compounds and complex antigens. Targeting steroids, peptides, small molecules, toxins, lipids and polysaccharides (on fungi and bacteria), the company has developed strong expertise in immunology to break immunotolerance in rat and guinea pig species, generating monoclonal antibodies of high specificity and affinity. The antibodies are useful in the fields of hormones, toxins, autoimmune diseases and oncology.
Phone: 02 9698 2022
Biosynth carbohydrates
Within the carbohydrate product range, Biosynth offers tools for glycobiology, chemo-enzymatic...
Cayman Chemical Stem Cell Small Molecule Screening Library
The screening library contains more than 140 small molecules that are known either to induce...
Cayman Chemical Bio-Active Lipid I Screening Library (96-Well)
Cayman Chemical's Bio-Active Lipid I Screening Library consists of 13 plates and contains...
